Parametric Portfolio Associates’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $206M | Buy |
377,450
+17,897
| +5% | +$9.41M | 0.11% | 175 |
|
|
2021
Q4 | $237M | Buy |
359,553
+2,571
| +0.7% | +$1.61M | 0.12% | 146 |
|
|
2021
Q3 | $222M | Buy |
356,982
+6,968
| +2% | +$4.68M | 0.13% | 141 |
|
|
2021
Q2 | $221M | Buy |
350,014
+13,434
| +4% | +$7.42M | 0.12% | 148 |
|
|
2021
Q1 | $165M | Buy |
336,580
+16,515
| +5% | +$8.27M | 0.09% | 189 |
|
|
2020
Q4 | $160M | Buy |
320,065
+1,271
| +0.4% | +$569K | 0.1% | 174 |
|
|
2020
Q3 | $125M | Sell |
318,794
-12,675
| -4% | -$4.69M | 0.09% | 189 |
|
|
2020
Q2 | $109M | Buy |
331,469
+11,655
| +4% | +$3.37M | 0.08% | 204 |
|
|
2020
Q1 | $77.5M | Buy |
319,814
+13,322
| +4% | +$3.48M | 0.07% | 245 |
|
|
2019
Q4 | $80M | Sell |
306,492
-1,322
| -0.4% | -$348K | 0.06% | 301 |
|
|
2019
Q3 | $83.7M | Buy |
307,814
+8,151
| +3% | +$2.27M | 0.07% | 277 |
|
|
2019
Q2 | $82.5M | Buy |
299,663
+12,317
| +4% | +$3.03M | 0.07% | 270 |
|
|
2019
Q1 | $64.3M | Buy |
287,346
+22,819
| +9% | +$4.71M | 0.06% | 315 |
|
|
2018
Q4 | $49.2M | Buy |
264,527
+24,467
| +10% | +$5.02M | 0.05% | 347 |
|
|
2018
Q3 | $59.9M | Sell |
240,060
-21,096
| -8% | -$5.12M | 0.05% | 330 |
|
|
2018
Q2 | $56.9M | Sell |
261,156
-962
| -0.4% | -$198K | 0.05% | 335 |
|
|
2018
Q1 | $50.2M | Buy |
262,118
+5,481
| +2% | +$1.01M | 0.05% | 360 |
|
|
2017
Q4 | $40.1M | Buy |
256,637
+13,994
| +6% | +$2.2M | 0.04% | 451 |
|
|
2017
Q3 | $37.7M | Sell |
242,643
-24,331
| -9% | -$3.85M | 0.04% | 442 |
|
|
2017
Q2 | $43.1M | Buy |
266,974
+122,184
| +84% | +$19.8M | 0.05% | 364 |
|
|
2017
Q1 | $22.4M | Sell |
144,790
-129,051
| -47% | -$17.8M | 0.03% | 558 |
|
|
2016
Q4 | $32.1M | Sell |
273,841
-2,915
| -1% | -$333K | 0.04% | 423 |
|
|
2016
Q3 | $31.2M | Sell |
276,756
-7,146
| -3% | -$753K | 0.05% | 389 |
|
|
2016
Q2 | $26.4M | Buy |
283,902
+28,586
| +11% | +$2.45M | 0.04% | 447 |
|
|
2016
Q1 | $20M | Buy |
255,316
+11,272
| +5% | +$812K | 0.03% | 528 |
|
|
2015
Q4 | $17.8M | Buy |
244,044
+8,541
| +4% | +$609K | 0.03% | 544 |
|
|
2015
Q3 | $17.5M | Buy |
235,503
+7,008
| +3% | +$502K | 0.03% | 526 |
|
|
2015
Q2 | $14.7M | Buy |
228,495
+2,837
| +1% | +$196K | 0.03% | 617 |
|
|
2015
Q1 | $17.4M | Sell |
225,658
-36,732
| -14% | -$2.86M | 0.04% | 530 |
|
|
2014
Q4 | $19.5M | Buy |
262,390
+938
| +0.4% | +$65.8K | 0.04% | 465 |
|
|
2014
Q3 | $15.4M | Buy |
261,452
+6,924
| +3% | +$438K | 0.03% | 552 |
|
|
2014
Q2 | $17M | Buy |
254,528
+10,698
| +4% | +$680K | 0.04% | 519 |
|
|
2014
Q1 | $14.8M | Buy |
243,830
+876
| +0.4% | +$52.2K | 0.04% | 545 |
|
|
2013
Q4 | $12.9M | Sell |
242,954
-150,330
| -38% | -$7.91M | 0.03% | 590 |
|
|
2013
Q3 | $19.6M | Buy |
393,284
+9,892
| +3% | +$475K | 0.05% | 391 |
|
|
2013
Q2 | $17.2M | Buy |
+383,392
| New | +$16.8M | 0.05% | 410 |
|
Other funds holding IDXX
Parametric Portfolio Associates's IDXX Position: Q1 2022 in Review
Parametric Portfolio Associates increased its Idexx Laboratories (IDXX) stake by 5% in Q1 2022, buying an estimated $9.41M and bringing the position to 377,450 shares worth $206M. The position accounts for 0.11% of the portfolio, ranked #175.
Parametric Portfolio Associates first reported a position in IDXX in Q2 2013 and has held it in 36 quarters since. The position peaked at $237M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.
- Parametric Portfolio Associates held 377,450 shares of Idexx Laboratories worth $206M as of Q1 2022.
- Parametric Portfolio Associates bought 17,897 Idexx Laboratories shares in Q1 2022, an estimated $9.41M.
- Idexx Laboratories made up 0.11% of Parametric Portfolio Associates's portfolio in Q1 2022, its #175 holding.
- Parametric Portfolio Associates first reported a position in Idexx Laboratories in Q2 2013 and has held it in 36 quarters since.
- Parametric Portfolio Associates's Idexx Laboratories position peaked at $237M in Q4 2021.
- 1,031 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.
Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.